Methylation profiling

Dataset Information

0

Multilineage pituitary neuroendocrine tumors with PIT1/SF1 co-expression


ABSTRACT: Pituitary neuroendocrine tumors (PitNET)/adenomas are classified according to cell lineage, which requires immunohistochemistry for the transcription factors (TFs) PIT1, SF1, and TPIT. Co-expression of PIT1/SF1 was previously reported in PitNETs, which otherwise correspond to the somatotroph lineage. However, little is known about the clinicopathological features of these tumors. We compiled an in-house case series of 100 tumors, previously diagnosed as densely or sparsely granulated somatotroph PitNETs. Following TF staining, histopathological features associated with PIT1/SF1-coexpression were assessed. Global DNA methylation profiling was conducted on 31 of 100 in-house samples and integrated with publicly available sample data. The majority (74%, 52/70) of our densely granulated somatotroph PitNETs (DGST) unequivocally co-expressed PIT1 and SF1 (DGST-PIT1/SF1). None of our SGST (0%, 0/30) stained positive for SF1 (SGST-PIT1). Integrated molecular analyses including publicly available sample data confirmed that DGST-PIT1/SF1, DGST-PIT1 and SGST-PIT1 represent distinct tumour subtypes. In summary, we spotlight that a substantial proportion of previously diagnosed densely granulated somatotroph PitNET co-express PIT1 and SF1 and exhibit clinical, histopathological, and molecular distinctness from other pure PIT1-lineage somatotroph PitNET.

ORGANISM(S): Homo sapiens

PROVIDER: GSE246645 | GEO | 2024/01/24

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| EGAS00001003642 | EGA
2023-09-25 | GSE226764 | GEO
2022-04-08 | GSE200175 | GEO
2024-04-28 | GSE264621 | GEO
2022-02-16 | GSE196647 | GEO
2024-04-26 | GSE240781 | GEO
| PRJNA1034042 | ENA
2024-09-25 | GSE269321 | GEO
2024-09-25 | GSE269044 | GEO
2018-02-21 | GSE100334 | GEO